The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition
Open Access
- 1 November 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (11) , 2416-2424
- https://doi.org/10.1158/1055-9965.epi-07-0256
Abstract
Previous studies have shown inconsistent associations of folate intake and polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene with gastric cancer risk. Our nested case-control study within the European Prospective Investigation into Cancer and Nutrition cohort is the first prospective study of blood folate levels and gastric cancer. Gastric cancer cases (n = 247) and controls (n = 631) were matched for study center, age, sex, and time of blood donation. Two common single nucleotide polymorphisms of the MTHFR gene were determined, as were plasma concentrations of folate, cobalamin (vitamin B12), total homocysteine, and methylmalonic acid (cobalamin deficiency marker) in prediagnostic plasma. Risk measures were calculated with conditional logistic regression. Although no relations were observed between plasma folate or total homocysteine concentrations and gastric cancer, we observed a trend toward lower risk of gastric cancer with increasing cobalamin concentrations (odds ratio, 0.79 per SD increase in cobalamin; P = 0.01). Further analyses showed that the inverse association between cobalamin and gastric cancer was confined to cancer cases with low pepsinogen A levels (marker of severe chronic atrophic gastritis) at the time of blood sampling. The 677 C→T MTHFR polymorphism was not associated with gastric cancer, but we observed an increased risk with the variant genotype of the 1298 A→C polymorphism (odds ratio, 1.47 for CC versus AA; P = 0.04). In conclusion, we found no evidence of a role of folate in gastric cancer etiology. However, we observed increased gastric cancer risk at low cobalamin levels that was most likely due to compromised cobalamin status in atrophic gastritis preceding gastric cancer. (Cancer Epidemiol Biomarkers Prev 2007;16(11):2416–24)Keywords
This publication has 52 references indexed in Scilit:
- Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolismHuman Mutation, 2007
- Genetic Polymorphisms in Folate Metabolism and the Risk of Stomach CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- Functional inference of the methylenetetrahydrofolate reductase 677 C > T and 1298A > C polymorphisms from a large-scale epidemiological studyHuman Genetics, 2006
- Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutritionBritish Journal of Cancer, 2006
- Case‐parent Triads: Estimating Single‐ and Double‐dose Effects of Fetal and Maternal Disease Gene HaplotypesAnnals of Human Genetics, 2006
- Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in MexicoEuropean Journal Of Cancer, 2006
- Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk populationDiseases of the Esophagus, 2005
- Diet and cancer — the European Prospective Investigation into Cancer and NutritionNature Reviews Cancer, 2004
- The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinomaCancer, 1997
- Adenocarcinomas of the esophagus and gastric cardia: The role of dietNutrition and Cancer, 1997